SDHC and hepatocellular carcinoma: As one of the lines of evidence, downregulation of SDHC expression resulted in decreased mitochondrial SDH activity and increased ROS levels in hepatocellular carcinoma (HCC) cells, thereby promoting HCC cell growth and metastasis in vitro and in vivo (41).